|
|
|
Corporate Profile: Dendreon
| Summary: |
Dendreon is
a focused on the development of targeted therapies
for the treatment of cancer. The Company's innovative
approaches include therapeutic vaccines, monoclonal
antibodies and small molecule product candidates. |
| Address:
|
3005 First Avenue
Seattle, WA 98121 |
| Phone
#'s: |
Main |
(206) 256-4545 |
| Human Resources |
(206) 256-4545 |
| Investor Relations |
(206) 829-1500 |
| Fax
#'s: |
Main |
(206) 256-0571 |
| Human Resources |
(206) 256-0571 |
| Investor Relations |
(206) 256-0571 |
| Financial
information: |
| DNDN |
| Patent
position: |
U.S. patents 1976-present: patent
link. |
|
|
|
